MNOV - MediciNova - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNOV is currently covered by 2 analysts with an average price target of $7.08. This is a potential upside of $5.42 (326.51%) from yesterday's end of day stock price of $1.66.

MediciNova's activity chart (see below) currently has 1 price targets and 9 ratings on display. The stock rating distribution of MNOV is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for MNOV is $5, Lowest price target is $5, average price target is $5.

Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 22-Sep-2025. First documented stock forecast 25-Mar-2019.

Best performing analysts who are covering MNOV - MediciNova:

Jason Kolbert Chad Mabry

Currently out of the existing stock ratings of MNOV, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 months 10 days ago
(22-Sep-2025)

0/3 (0%)

$7.17 (391.80%)

Buy

$5

$3.77 (306.50%)

$22

4 months 16 days ago
(16-Jun-2025)

0/2 (0%)

$3.67 (275.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNOV (MediciNova) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MNOV (MediciNova) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on MNOV (MediciNova) with a proven track record?

CHAD MABRY

Which analyst has the most public recommendations on MNOV (MediciNova)?

Jason Kolbert has 5 price targets and 8 ratings on MNOV

Which analyst is the currently most bullish on MNOV (MediciNova)?

Chad Mabry with highest potential upside - $3.77

Which analyst is the currently most reserved on MNOV (MediciNova)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?